HLF vs NUS
Herbalife Ltd. and NU Skin Enterprises, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | HLF | NUS |
|---|---|---|
| Revenue | $5.0B | $1.5B |
| Net income | $228.3M | $160.2M |
| Gross margin | 77.9% | 69.4% |
| Net margin | 4.5% | 10.8% |
| Return on equity | 364.1% | 22.0% |
| Diluted EPS | $2.20 | $3.18 |
| Dividend / share | $0.30 | $0.35 |
| Payout ratio | 0.0% | 7.4% |
| Free cash flow | $252.9M | $46.0M |
| Equity | $-515.1M | $805.2M |
| Net debt / equity | 3.01× | −0.02× |
| Current ratio | 1.13× | 2.08× |
| Revenue CAGR 5y | −1.9% | −10.5% |
| Profit CAGR 5y | −9.3% | −3.5% |
HLF bills 3.4× the revenue of NUS, and NUS keeps more of each dollar of revenue as profit (10.8% against 4.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | HLF | NUS |
|---|---|---|
| FY2025 | $5.0B | $1.5B |
| FY2024 | $5.0B | $1.7B |
| FY2023 | $5.1B | $2.0B |
| FY2022 | $5.2B | $2.2B |
| FY2021 | $5.8B | $2.7B |
| FY2020 | $5.5B | $2.6B |
| FY2019 | $4.9B | $2.4B |
| FY2018 | $4.9B | $2.7B |
| FY2017 | $4.4B | $2.3B |
| FY2016 | $4.5B | $2.2B |
Net income by year
Bottom line
| Fiscal year | HLF | NUS |
|---|---|---|
| FY2025 | $228.3M | $160.2M |
| FY2024 | $254.3M | $-146.6M |
| FY2023 | $142.2M | $8.6M |
| FY2022 | $321.3M | $104.8M |
| FY2021 | $447.2M | $147.3M |
| FY2020 | $372.6M | $191.4M |
| FY2019 | $311.0M | $173.6M |
| FY2018 | $296.6M | $121.9M |
| FY2017 | $213.9M | $129.4M |
| FY2016 | $260.0M | $143.1M |
Advertisement
AdSense · Rectangle 336×280